Pharma Co News Today

Days of land. The plant produces Clean Electricity from when the sun at the same time, good job of was ideal conditions for the hybrid system, situated near the tropic of cancer and the already been see, it has plenty of in, on more than 300. 00 days of sunshine. Are you open . It does have long since discovered the region. Why the joint these will distance for vin . So lets have your projects. So this means um, in terms of the, ill give you some in terms of the dirtiest one is better. So then y...

Economically its going to be a disaster. Socially. Its going to be a disaster. We simply dont know yet. What will happen in the chair and were preparing for the alternative options. Also on the day, russia is raising the age of compulsory military service. Officials say recruits wont be sent to fight in ukraine, but many are afraid. Thats exactly what awaits them. Did you question them in the system . What is that . At the moment that the russia is lacking, troops was navigated. They ways, its t...

ChrysCapital is close to acquiring 5-6% stake in La Renon Healthcare, a pharmaceutical company engaged in manufacturing and marketing of branded generic formulations. ChrysCapital will buy shares from early angel investors and possibly from promoter Pankaj Singh and family. La Renons nutritional supplement brand is featured in the top 300 formulation brands in the domestic market.

India News: A Bulgarian flight attendant has filed a complaint with the Gujarat High Court, alleging that the state police have refused to register an FIR against

Co-CEOs Santiago Pujadas and Ngoc Thai said the funding will be put toward hiring and expanding the development of therapies and treatments for diseases with fewer available medical options.

Appointment culminates multi-year succession plan as FSD focuses on commercialization of its UNBUZZD™ alcohol misuse product and Lucid-MS for neurodegenerative disorders

VANCOUVER, BC / ACCESSWIRE / December 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company today announced a strategic move to sell its wholly owned subsidiary Microdoz

Please see the previously announced news from Starton Therapeutics Inc.VANCOUVER, BC / ACCESSWIRE / November 2, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company")(CSE:LUV)(FSE:G1Q0), is please to announce

VANCOUVER, BC / ACCESSWIRE / October 19, 2022 / LOVE Pharma Co. ("LOVE" or the "Company") (CSE:LUV) (FSE:G1Q0), is pleased to announce that it has completed its acquisition (the "Acquisition") ofDoc Hygiene

Dr. Albert Garcia Romeu will serve as head researcher for the Love Pharma's MicroDoz sponsored trial to be conducted at the Johns Hopkins Center for Psychedelic and Consciousness ResearchThe MicroDoz Therapy